89 related articles for article (PubMed ID: 30406628)
21. Adrenal incidentaloma: a new cause of the metabolic syndrome?
Terzolo M; Pia A; Alì A; Osella G; Reimondo G; Bovio S; Daffara F; Procopio M; Paccotti P; Borretta G; Angeli A
J Clin Endocrinol Metab; 2002 Mar; 87(3):998-1003. PubMed ID: 11889151
[TBL] [Abstract][Full Text] [Related]
22. Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk.
Tauchmanovà L; Rossi R; Biondi B; Pulcrano M; Nuzzo V; Palmieri EA; Fazio S; Lombardi G
J Clin Endocrinol Metab; 2002 Nov; 87(11):4872-8. PubMed ID: 12414841
[TBL] [Abstract][Full Text] [Related]
23. Comparison of Three Adiposity Indexes and Cutoff Values to Predict Metabolic Syndrome Among University Students.
Correa-Bautista JE; González-Ruíz K; Vivas A; Triana-Reina HR; Martínez-Torres J; Prieto-Benavides DH; Carrillo HA; Ramos-Sepúlveda JA; Afanador-Rodríguez MI; Villa-González E; García-Hermoso A; Ramírez-Vélez R
Metab Syndr Relat Disord; 2017 Sep; 15(7):363-370. PubMed ID: 28570830
[TBL] [Abstract][Full Text] [Related]
24. Nonfunctioning adrenal incidentaloma: A novel predictive factor for metabolic syndrome.
Ribeiro Cavalari EM; de Paula MP; Arruda M; Carraro N; Martins A; de Souza K; Coelho MC; de Oliveira E Silva de Morais NA; Moraes AB; Vieira Neto L
Clin Endocrinol (Oxf); 2018 Nov; 89(5):586-595. PubMed ID: 30044007
[TBL] [Abstract][Full Text] [Related]
25. Metabolic syndrome and low high-density lipoprotein cholesterol are associated with adverse pathological features in patients with prostate cancer treated by radical prostatectomy.
Lebdai S; Mathieu R; Leger J; Haillot O; Vincendeau S; Rioux-Leclercq N; Fournier G; Perrouin-Verbe MA; Doucet L; Azzouzi AR; Rigaud J; Renaudin K; Charles T; Bruyere F; Fromont G
Urol Oncol; 2018 Feb; 36(2):80.e17-80.e24. PubMed ID: 29153942
[TBL] [Abstract][Full Text] [Related]
26. Bilateral adrenal incidentalomas differ from unilateral adrenal incidentalomas in subclinical cortisol hypersecretion but not in potential clinical implications.
Vassilatou E; Vryonidou A; Ioannidis D; Paschou SA; Panagou M; Tzavara I
Eur J Endocrinol; 2014 Jul; 171(1):37-45. PubMed ID: 24743396
[TBL] [Abstract][Full Text] [Related]
27. Nationwide review of hormonally active adrenal tumors highlights high morbidity in pheochromocytoma.
Parikh PP; Rubio GA; Farra JC; Lew JI
J Surg Res; 2017 Jul; 215():204-210. PubMed ID: 28688648
[TBL] [Abstract][Full Text] [Related]
28. Determinants of Incident Metabolic Syndrome in a Middle Eastern Population: Isfahan Cohort Study.
Hosseini N; Talaei M; Dianatkhah M; Sadeghi M; Oveisgharan S; Sarrafzadegan N
Metab Syndr Relat Disord; 2017 Sep; 15(7):354-362. PubMed ID: 28677982
[TBL] [Abstract][Full Text] [Related]
29. Hormonal activity of adrenal incidentalomas: results from a long-term follow-up study.
Vassilatou E; Vryonidou A; Michalopoulou S; Manolis J; Caratzas J; Phenekos C; Tzavara I
Clin Endocrinol (Oxf); 2009 May; 70(5):674-9. PubMed ID: 19067718
[TBL] [Abstract][Full Text] [Related]
30. Targeted High Performance Liquid Chromatography Tandem Mass Spectrometry-based Metabolomics differentiates metabolic syndrome from obesity.
Zhong F; Xu M; Bruno RS; Ballard KD; Zhu J
Exp Biol Med (Maywood); 2017 Apr; 242(7):773-780. PubMed ID: 28299975
[TBL] [Abstract][Full Text] [Related]
31. Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study.
Di Dalmazi G; Vicennati V; Garelli S; Casadio E; Rinaldi E; Giampalma E; Mosconi C; Golfieri R; Paccapelo A; Pagotto U; Pasquali R
Lancet Diabetes Endocrinol; 2014 May; 2(5):396-405. PubMed ID: 24795253
[TBL] [Abstract][Full Text] [Related]
32. Anthropometric cutoff values for predicting metabolic syndrome in a Saudi community: from the SAUDI-DM study.
Al-Rubean K; Youssef AM; AlFarsi Y; Al-Sharqawi AH; Bawazeer N; AlOtaibi MT; AlRumaih FI; Zaidi MS
Ann Saudi Med; 2017; 37(1):21-30. PubMed ID: 28151453
[TBL] [Abstract][Full Text] [Related]
33. Age and gender-specific distribution of metabolic syndrome components in East China: role of hypertriglyceridemia in the SPECT-China study.
Jiang B; Zheng Y; Chen Y; Chen Y; Li Q; Zhu C; Wang N; Han B; Zhai H; Lin D; Lu Y
Lipids Health Dis; 2018 Apr; 17(1):92. PubMed ID: 29678174
[TBL] [Abstract][Full Text] [Related]
34. Comparison of Lipid Accumulation Product Index with Body Mass Index and Waist Circumference as a Predictor of Metabolic Syndrome in Indian Population.
Ray L; Ravichandran K; Nanda SK
Metab Syndr Relat Disord; 2018 Jun; 16(5):240-245. PubMed ID: 29648916
[TBL] [Abstract][Full Text] [Related]
35. Subclinical Cushing's syndrome in adrenal incidentalomas--possible metabolic consequences.
Bohdanowicz-Pawlak A; Szymczak J; Waszczuk E; Bolanowski M; Bednarek-Tupikowska G
Endokrynol Pol; 2013; 64(3):186-91. PubMed ID: 23873421
[TBL] [Abstract][Full Text] [Related]
36. Multimarker Assessment of Diastolic Dysfunction in Metabolic Syndrome Patients.
Mocan M; Anton F; Suciu Ș; Răhăian R; Blaga SN; Fărcaș AD
Metab Syndr Relat Disord; 2017 Dec; 15(10):507-514. PubMed ID: 29099655
[TBL] [Abstract][Full Text] [Related]
37. Comparison of anthropometric indices for predicting the risk of metabolic syndrome and its components in Chinese adults: a prospective, longitudinal study.
Wang H; Liu A; Zhao T; Gong X; Pang T; Zhou Y; Xiao Y; Yan Y; Fan C; Teng W; Lai Y; Shan Z
BMJ Open; 2017 Sep; 7(9):e016062. PubMed ID: 28928179
[TBL] [Abstract][Full Text] [Related]
38. Greater impairment of postprandial triacylglycerol than glucose response in metabolic syndrome subjects with fasting hyperglycaemia.
Jackson KG; Walden CM; Murray P; Smith AM; Minihane AM; Lovegrove JA; Williams CM
Metabolism; 2013 Aug; 62(8):1065-9. PubMed ID: 23598085
[TBL] [Abstract][Full Text] [Related]
39. Clinical and endocrinological characteristics of adrenal incidentaloma in Osaka region, Japan.
Tabuchi Y; Otsuki M; Kasayama S; Kosugi K; Hashimoto K; Yamamoto T; Tsugawa M; Mineo I; Yamada Y; Kurebayashi S; Ohashi M; Umayahara Y; Kouhara H; Nakamura T; Taki H; Matsuoka TA; Imagawa A; Funahashi T; Shimomura I
Endocr J; 2016; 63(1):29-35. PubMed ID: 26490049
[TBL] [Abstract][Full Text] [Related]
40. [The value of fasting plasma glucose and lipid profiles between 7 and 15 gestational weeks in the prediction of gestational diabetes mellitus].
Zhao M; Li GH
Zhonghua Fu Chan Ke Za Zhi; 2016 Nov; 51(11):835-839. PubMed ID: 27916067
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
